Sculptor Capital LP - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 102 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
Sculptor Capital LP ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$488,000
-18.1%
725,6000.0%0.00%
-75.0%
Q1 2019$596,000
-48.6%
725,6000.0%0.00%
-50.0%
Q4 2018$1,160,000725,6000.01%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,866,483$4,285,0002.24%
Sarissa Capital Management LP 2,570,759$3,843,0001.32%
Greylock XI GP Limited Partnership 584,004$876,0000.56%
Deer VI & Co. LLC 675,242$1,013,0000.44%
DAFNA Capital Management LLC 261,507$391,0000.34%
Palo Alto Investors LP 2,858,348$4,274,0000.18%
Baupost Group 3,829,350$5,725,0000.14%
SABBY MANAGEMENT, LLC 573,416$857,0000.05%
Granahan Investment Management 676,451$1,011,0000.03%
TFS CAPITAL LLC 176,633$264,0000.02%
View complete list of AVEO PHARMACEUTICALS INC shareholders